Dianthus Therapeutics Inc (DNTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DNTH | CRSP | KNSA | ||
| Company | Dianthus Therapeutics Inc | Crispr Therapeutics Ag | Kiniksa Pharmaceuticals International Plc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 85.47 | 53.05 | 57.06 | ||
| High | 88.74 | 55.85 | 58.85 | ||
| Low | 85.00 | 52.55 | 56.83 | ||
| Latest | 86.71 | 54.83 | 58.60 | ||
| Change | +1.24 | +2.41 | +1.67 | ||
| % Change | +1.45% | +4.60% | +2.93% | ||
| Volume | 517,000 | 1,733,400 | 394,200 | ||
| 20-Day Average Volume | 542,620 | 1,936,635 | 915,485 | ||
| Previous Close | 85.47 | 52.42 | 56.93 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 89.46 | 54.09 | 49.59 | ||
| 20-Day Raw Stochastic | 32.48% | 57.06% | 98.56% | ||
| 20-Day Relative Strength | 54.48 | 53.28 | 69.49 | ||
| Weighted Alpha | +311.38 | +35.57 | +106.94 | ||
| Today's Opinion | 80% Buy | 16% Sell | 100% Buy | ||
| Previous Opinion | 80% Buy | 48% Sell | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 72% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.81% since 05/01/26 | +6.20% since 05/01/26 | +6.02% since 05/01/26 | ||
| Low | 83.56 on 05/07/26 | 49.38 on 05/05/26 | 54.45 on 05/04/26 | ||
| High | 91.81 on 05/06/26 | 55.85 on 05/08/26 | 58.85 on 05/08/26 | ||
| 1-Month | |||||
| %Chg | -0.88% since 04/08/26 | +5.93% since 04/08/26 | +24.60% since 04/08/26 | ||
| Low | 82.00 on 04/29/26 | 48.77 on 04/24/26 | 41.49 on 04/21/26 | ||
| High | 96.50 on 04/16/26 | 59.39 on 04/15/26 | 58.85 on 05/08/26 | ||
| 3-Month | |||||
| %Chg | +70.86% since 02/06/26 | +12.49% since 02/06/26 | +35.99% since 02/06/26 | ||
| Low | 45.64 on 02/12/26 | 44.12 on 03/30/26 | 41.12 on 02/24/26 | ||
| High | 96.50 on 04/16/26 | 61.76 on 02/26/26 | 58.85 on 05/08/26 | ||
| 6-Month | |||||
| %Chg | +139.00% since 11/07/25 | -0.53% since 11/07/25 | +52.72% since 11/07/25 | ||
| Low | 34.29 on 11/14/25 | 44.12 on 03/30/26 | 37.02 on 01/15/26 | ||
| High | 96.50 on 04/16/26 | 61.76 on 02/26/26 | 58.85 on 05/08/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,672,303 | 5,055,856 | 4,357,138 | ||
| Shares Outstanding, K | 54,666 | 96,449 | 76,535 | ||
| Annual Sales | 2,040,000 | 3,510,000 | 677,560,000 | ||
| Annual Net Income | -162,340,000 | -581,600,000 | 59,010,000 | ||
| Last Quarter Sales | 280,000 | 860,000 | 214,270,000 | ||
| Last Quarter Net Income | -64,430,000 | -130,610,000 | 22,590,000 | ||
| 60-Month Beta | 1.18 | 1.74 | 0.17 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.85 on 05/05/26 | -1.28 on 05/04/26 | 0.27 on 04/28/26 | ||
| Earnings Date | 08/06/26 | 08/03/26 | 08/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 64.70 | ||